Lau, H., & Hu, K. (2024). S1764 Risk Factors, Clinical Presentation and Non-Invasive Liver Fibrosis Tests for Advanced Liver Fibrosis in Biopsy Diagnosed Metabolic Dysfunction-Associated Steatotic Liver Disease or Steatohepatitis. The American journal of gastroenterology, 119(10S), S1277-S1278. https://doi.org/10.14309/01.ajg.0001036424.33995.a8
Citácia podle Chicago (17th ed.)Lau, Hien, a Ke-Qin Hu. "S1764 Risk Factors, Clinical Presentation and Non-Invasive Liver Fibrosis Tests for Advanced Liver Fibrosis in Biopsy Diagnosed Metabolic Dysfunction-Associated Steatotic Liver Disease or Steatohepatitis." The American Journal of Gastroenterology 119, no. 10S (2024): S1277-S1278. https://doi.org/10.14309/01.ajg.0001036424.33995.a8.
Citácia podľa MLA (8th ed.)Lau, Hien, a Ke-Qin Hu. "S1764 Risk Factors, Clinical Presentation and Non-Invasive Liver Fibrosis Tests for Advanced Liver Fibrosis in Biopsy Diagnosed Metabolic Dysfunction-Associated Steatotic Liver Disease or Steatohepatitis." The American Journal of Gastroenterology, vol. 119, no. 10S, 2024, pp. S1277-S1278, https://doi.org/10.14309/01.ajg.0001036424.33995.a8.